{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:42:47Z","timestamp":1761493367348,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["ESR-14-10099"],"award-info":[{"award-number":["ESR-14-10099"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcjd.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T20:15:41Z","timestamp":1584994541000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study"],"prefix":"10.1016","volume":"44","author":[{"given":"Nobuko","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-0550","authenticated-orcid":false,"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2020.03.004_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased motality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/10408363.2017.1377682","article-title":"Biomarkers of diabetic nephropathy: A 2017 update","volume":"54","author":"Papadopoulou-Marketou","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jcjd.2020.03.004_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcjd.2020.03.004_bib4","doi-asserted-by":"crossref","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcjd.2020.03.004_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib6","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","article-title":"Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: A population-based longitudinal study","volume":"43","author":"Okamura","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jcjd.2020.03.004_bib8","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","article-title":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcjd.2020.03.004_bib9","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis","volume":"22","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcjd.2020.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142808","article-title":"Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2020.03.004_bib11","first-page":"32334","article-title":"Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes","volume":"17","author":"Yeung","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.orcp.2017.12.003","article-title":"Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies","volume":"12","author":"Hashimoto","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2020.03.004_bib13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","article-title":"Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines","volume":"22","author":"Chitturi","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jdi.12319","article-title":"A\u00a0new classification of diabetic nephropathy 2014: A report from Joint Committee on Diabetic Nephropathy","volume":"6","author":"Haneda","year":"2015","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.jcjd.2020.03.004_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcjd.2020.03.004_bib16","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2337\/dc12-2087","article-title":"Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes","volume":"36","author":"Okada","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2020.03.004_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1507\/endocrj.EJ16-0124","article-title":"The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes","volume":"63","author":"Hashimoto","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.jcjd.2020.03.004_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabet.2016.07.035","article-title":"Relationship between skeletal muscle mass and hepatic fibrosis in patients with type 2 diabetes","volume":"43","author":"Osaka","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjd.2020.03.004_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.hepres.2004.03.007","article-title":"Efficacy of non-invasive elastometry on staging of hepatic fibrosis","volume":"29","author":"Saito","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jcjd.2020.03.004_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcjd.2020.03.004_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease","volume":"19","author":"Targher","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatosis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jcjd.2020.03.004_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1445-5994.2009.01979.x","article-title":"Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes","volume":"40","author":"Hwang","year":"2010","journal-title":"Intern Med J"},{"key":"10.1016\/j.jcjd.2020.03.004_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00109-009-0464-1","article-title":"Molecular mechanisms involved in NAFLD progression","volume":"87","author":"Malaguarnera","year":"2009","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jcjd.2020.03.004_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: Mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ndt\/gfm674","article-title":"Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients","volume":"23","author":"Navarro","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcjd.2020.03.004_bib31","first-page":"394206","article-title":"TNF-\u03b1 and microalbuminuria in patients with type 2 diabetes mellitus","volume":"2014","author":"Lampropoulou","year":"2014","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jcjd.2020.03.004_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"Osterreicher","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcjd.2020.03.004_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3904\/kjim.2017.317","article-title":"Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension","volume":"33","author":"Shim","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jcjd.2020.03.004_bib35","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1046\/j.1523-1755.2000.07715.x","article-title":"Role of angiotensin II in diabetic nephropathy","volume":"77","author":"Leehey","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jcjd.2020.03.004_bib36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/10.8.1305","article-title":"Angiotensin-II-induced cell hypertrophy: Potential role of impaired proteolytic activity in cultured LLC-PK1 cells","volume":"10","author":"Ling","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcjd.2020.03.004_bib37","first-page":"976","article-title":"Managing vascular risk in hypertension with a focus on microalbuminuria: Attitude and practices","volume":"50","author":"Wu","year":"2009","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jcjd.2020.03.004_bib38","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2020.03.004_bib39","doi-asserted-by":"crossref","unstructured":"Neal B, Perkovic V, Mahaffey KW, et\u00a0al. CANVAS Program Collaborative Group (2017) canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377:644\u2013657.","DOI":"10.1056\/NEJMoa1611925"},{"key":"10.1016\/j.jcjd.2020.03.004_bib40","doi-asserted-by":"crossref","unstructured":"Mann JFE, \u00d8rsted DD, Brown-Frandsen K, et\u00a0al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 377:839\u201348.","DOI":"10.1056\/NEJMoa1616011"},{"key":"10.1016\/j.jcjd.2020.03.004_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"de L\u00e9dinghen","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jcjd.2020.03.004_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00535-008-2225-2","article-title":"Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases","volume":"43","author":"Obara","year":"2008","journal-title":"J\u00a0Gastroenterol"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267120300770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267120300770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:34:55Z","timestamp":1761492895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267120300770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1499267120300770"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2020.03.004","relation":{},"ISSN":["1499-2671"],"issn-type":[{"type":"print","value":"1499-2671"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}